A Care Process Model to Deliver (177)Lu-Dotatate Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors

Purpose: To develop a care process model for the delivery of peptide receptor radionuclide therapy (PRRT) with lutetium-177 ((177)Lu)-Dotatate for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Methods: A multidisciplinary, structured PRRT pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasi, Pashtoon Murtaza, Maige, Catherine L., Shahjehan, Faisal, Rodgers, Jessica M., Aloszka, Debora L., Ritter, Ashton, Andrus, Margaret L., Mcmillan, Jessica M., Mody, Kabir, Sharma, Akash, Jain, Manoj K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333662/
https://www.ncbi.nlm.nih.gov/pubmed/30687638
http://dx.doi.org/10.3389/fonc.2018.00663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333662/
https://www.ncbi.nlm.nih.gov/pubmed/30687638
http://dx.doi.org/10.3389/fonc.2018.00663

Ejemplares similares